Download PDF
Semin Respir Crit Care Med 2023; 44(01): 130-142
DOI: 10.1055/s-0042-1759568
Review Article

“Long Haulers”

Denyse D. Lutchmansingh
1   Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
,
Jean Paul Higuero Sevilla
1   Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
,
Jennifer D. Possick
1   Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
,
Mridu Gulati
1   Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
› Author Affiliations Funding M.G. is supported by a grant from NHLBI (grant no.: R01 HL12580–01A1), Boehringer Ingelheim, and the Pulmonary Fibrosis Foundation
› Further Information
    Permissions and Reprints

Abstract

Post-COVID conditions continue to afflict patients long after acute severe acute respiratory syndrome-coronavirus-2 (SARS CoV-2) infection. Over 50 symptoms across multiple organ systems have been reported, with pulmonary, cardiovascular, and neuropsychiatric sequelae occurring most frequently. Multiple terms have been used to describe post-COVID conditions including long COVID, long-haul COVID, postacute coronavirus disease 2019 (COVID-19), postacute sequelae of SARS-CoV-2 infection, long-term effects of COVID, and chronic COVID-19; however, standardized assessments and treatment algorithms for patients have generally been lacking. This review discusses the epidemiology and risk factors for post-COVID conditions and provides a general overview of the diagnostic assessment and treatment of specific manifestations. Data derived from the multitude of observational studies and scientific investigations into pathogenesis are providing a clearer understanding of the distinct phenotypes of post-COVID conditions. Insight gained from these studies and ongoing interventional trials continues to lead to the development of clinical protocols directed toward improving COVID-19 survivors' quality of life and preventing or reducing long-term morbidity.

Keywords

long COVID - post-COVID conditions - SARS-CoV-2


Publication History

Article published online:
16 January 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 (WHO), W.H.O. World Health Organization Coronavirus (COVID-19) Dashboard. 2022. Accessed September 2, 2022 at: https://covid19.who.int/
    PubMed
  • 2 Hui DS, Wong KT, Ko FW. et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005; 128 (04) 2247-2261
    CrossrefPubMedGoogle Scholar
  • 3 Park WB, Jun KI, Kim G. et al. Correlation between pneumonia severity and pulmonary complications in Middle East Respiratory Syndrome. J Korean Med Sci 2018; 33 (24) e169-e169
    CrossrefPubMedGoogle Scholar
  • 4 Ahmed H, Patel K, Greenwood DC. et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med 2020; 52 (05) jrm00063
    CrossrefPubMedGoogle Scholar
  • 5 Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324 (06) 603-605
    CrossrefPubMedGoogle Scholar
  • 6 Garrigues E, Janvier P, Kherabi Y. et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 2020; 81 (06) e4-e6
    CrossrefPubMedGoogle Scholar
  • 7 CDC. Centers for Disease Control and Prevention Post COVID Conditions. 2021 Accessed September 16, 2021 at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/
    PubMedGoogle Scholar
  • 8 WHO. World Health Organization: a clinical case definition of post COVID-19 condition by a Delphi consensus. World Health Organization 2021. June 10, 2021 at: WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf.
    PubMedGoogle Scholar
  • 9 NICE. National Institute for Health and Care Excellence COVID-19. 2022 March 01, 2022. Accessed July 4, 2022 at: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742
    PubMedGoogle Scholar
  • 10 Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11 (01) 16144
    Google Scholar
  • 11 Nalbandian A, Sehgal K, Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27 (04) 601-615
    CrossrefPubMedGoogle Scholar
  • 12 CDC. Long COVID: Household Pulse Survey. Accessed November 16, 2022 at: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm
    PubMedGoogle Scholar
  • 13 Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) Condition or Long COVID: a meta-analysis and systematic review. J Infect Dis 2022; 226 (09) 1593-1607
    CrossrefPubMedGoogle Scholar
  • 14 Huang C, Huang L, Wang Y. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397 (10270): 220-232
    CrossrefPubMedGoogle Scholar
  • 15 Huang L, Yao Q, Gu X. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021; 398 (10302): 747-758
    CrossrefPubMedGoogle Scholar
  • 16 Huang L, Li X, Gu X. et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med 2022; 10 (09) 863-876
    CrossrefPubMedGoogle Scholar
  • 17 Arnold DT, Hamilton FW, Milne A. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021; 76 (04) 399-401
    CrossrefPubMedGoogle Scholar
  • 18 Davis HE, Assaf GS, McCorkell L. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019
    CrossrefPubMedGoogle Scholar
  • 19 AAPMR. CDC Announces Approval of ICD-10 Code for Post-Acute Sequelae of COVID-19 July 20, 2021. Accessed May 25th, 2022 at: https://www.aapmr.org/members-publications/member-news/member-news-details/2021/07/20/cdc-announces-approval-of-icd-10-code-for-post-acute-sequelae-of-covid-19
    PubMedGoogle Scholar
  • 20 FairHealth. Patients diagnosed with post-COVID conditions: an analysis of private healthcare claims using the official ICD-10 diagnostic code. FH White Papers. Accessed May 27, 2022 at: https://www.fairhealth.org/publications/whitepapers
    PubMedGoogle Scholar
  • 21 Ioannou GN, Baraff A, Fox A. et al. Rates and factors associated with documentation of diagnostic codes for long COVID in the National Veterans Affairs Health Care System. JAMA Netw Open 2022; 5 (07) e2224359
    CrossrefPubMedGoogle Scholar
  • 22 Subramanian A, Nirantharakumar K, Hughes S. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 2022; 28 (08) 1706-1714
    CrossrefPubMedGoogle Scholar
  • 23 Halpin SJ, McIvor C, Whyatt G. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 2021; 93 (02) 1013-1022
    CrossrefPubMedGoogle Scholar
  • 24 Hellemons ME, Huijts S, Bek LM. et al. Persistent health problems beyond pulmonary recovery up to 6 months after hospitalization for COVID-19: a longitudinal study of respiratory, physical, and psychological outcomes. Ann Am Thorac Soc 2022; 19 (04) 551-561
    CrossrefPubMedGoogle Scholar
  • 25 Moreno-Pérez O, Merino E, Leon-Ramirez JM. et al; COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect 2021; 82 (03) 378-383
    CrossrefPubMedGoogle Scholar
  • 26 PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022; 10 (08) 761-775
    CrossrefPubMedGoogle Scholar
  • 27 Pfaff ER, Girvin AT, Bennett TD. et al; N3C Consortium. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health 2022; 4 (07) e532-e541
    CrossrefPubMedGoogle Scholar
  • 28 Fumagalli C, Zocchi C, Tassetti L. et al; AOU Careggi COVID-19 Follow-up study Group. Factors associated with persistence of symptoms 1 year after COVID-19: a longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med 2022; 97: 36-41
    CrossrefPubMedGoogle Scholar
  • 29 Sudre CH, Murray B, Varsavsky T. et al. Attributes and predictors of long COVID. Nat Med 2021; 27 (04) 626-631
    CrossrefPubMedGoogle Scholar
  • 30 (CDC), C.f.D.C.a.P. Risk for COVID-19 Infection, Hospitalization, and Death by Race/Ethnicity. 2022. Accessed July 28, 2022 at: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html
    PubMedGoogle Scholar
  • 31 2021, N.S.C. Estimates of the prevalence and characteristics of people with self-reported “long COVID”, and associated activity limitation, using UK Coronavirus (COVID-19) Infection Survey data to 2 May 2021. Coronavirus (COVID-19) Infection Survey 2022. Accessed September 2, 2022 at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7april2022
    PubMedGoogle Scholar
  • 32 Ioannou GN. et al. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System. JAMA Netw Open 2022; 5 (07) e2224359
    CrossrefPubMedGoogle Scholar
  • 33 Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022; 28 (07) 1461-1467
    Google Scholar
  • 34 Hickie I, Davenport T, Wakefield D. et al; Dubbo Infection Outcomes Study Group. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006; 333 (7568): 575
    CrossrefPubMedGoogle Scholar
  • 35 Sneller MC, Reilly C, Badio M. et al; PREVAIL III Study Group. A longitudinal study of Ebola Sequelae in Liberia. N Engl J Med 2019; 380 (10) 924-934
    CrossrefPubMedGoogle Scholar
  • 36 Paixão ES, Rodrigues LC, Costa MDCN. et al. Chikungunya chronic disease: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg 2018; 112 (07) 301-316
    CrossrefPubMedGoogle Scholar
  • 37 Hung TM, Wills B, Clapham HE, Yacoub S, Turner HC. The uncertainty surrounding the burden of post-acute consequences of dengue infection. Trends Parasitol 2019; 35 (09) 673-676
    CrossrefPubMedGoogle Scholar
  • 38 Patel H, Sander B, Nelder MP. Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect Dis 2015; 15 (08) 951-959
    CrossrefPubMedGoogle Scholar
  • 39 Jason LA, Cotler J, Islam MF, Sunnquist M, Katz BZ. Risks for developing myalgic encephalomyelitis/chronic fatigue syndrome in college students following infectious mononucleosis: a prospective cohort study. Clin Infect Dis 2021; 73 (11) e3740-e3746
    CrossrefPubMedGoogle Scholar
  • 40 Morroy G, Keijmel SP, Delsing CE. et al. Fatigue following acute Q-fever: a systematic literature review. PLoS One 2016; 11 (05) e0155884
    CrossrefPubMedGoogle Scholar
  • 41 Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med 2022; 28 (05) 911-923
    CrossrefPubMedGoogle Scholar
  • 42 Cheung CCL, Goh D, Lim X. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 2022; 71 (01) 226-229
    CrossrefPubMedGoogle Scholar
  • 43 Swank Z, Senussi Y, Manickas-Hill Z. et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis 2022; (e-pub ahead of print) DOI: 10.1093/cid/ciac722.
    CrossrefPubMedGoogle Scholar
  • 44 Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 2021; 12: 698169
    CrossrefPubMedGoogle Scholar
  • 45 Wang EY, Mao T, Klein J. et al; Yale IMPACT Team. Diverse functional autoantibodies in patients with COVID-19. Nature 2021; 595 (7866): 283-288
    CrossrefPubMedGoogle Scholar
  • 46 Shoenfeld Y, Ryabkova VA, Scheibenbogen C. et al. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin Immunol 2020; 214: 108384
    CrossrefPubMedGoogle Scholar
  • 47 Scheibenbogen C, Loebel M, Freitag H. et al. Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME. PLoS One 2018; 13 (03) e0193672
    CrossrefPubMedGoogle Scholar
  • 48 Wallukat G, Hohberger B, Wenzel K. et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 2021; 4: 100100
    CrossrefPubMedGoogle Scholar
  • 49 Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome 2016; 4 (01) 30
    CrossrefPubMedGoogle Scholar
  • 50 Baldini F, Hertel J, Sandt E. et al; NCER-PD Consortium. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol 2020; 18 (01) 62
    CrossrefPubMedGoogle Scholar
  • 51 Nagy-Szakal D, Williams BL, Mishra N. et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome 2017; 5 (01) 44
    CrossrefPubMedGoogle Scholar
  • 52 Zuo T, Zhang F, Lui GCY. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 2020; 159 (03) 944-955.e8
    CrossrefPubMedGoogle Scholar
  • 53 Su Y, Yuan D, Chen DG. et al; ISB-Swedish COVID-19 Biobanking Unit. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022; 185 (05) 881-895.e20
    CrossrefPubMedGoogle Scholar
  • 54 Pretorius E, Vlok M, Venter C. et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 2021; 20 (01) 172
    CrossrefPubMedGoogle Scholar
  • 55 Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens 2021; 10 (06) 763
    CrossrefPubMedGoogle Scholar
  • 56 Ruhl L, Pink I, Kühne JF. et al. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks. Signal Transduct Target Ther 2021; 6 (01) 418
    CrossrefPubMedGoogle Scholar
  • 57 Oikonomou E, Souvaliotis N, Lampsas S. et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul Pharmacol 2022; 144: 106975
    CrossrefPubMedGoogle Scholar
  • 58 Zhang J, Tecson KM, McCullough PA. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Rev Cardiovasc Med 2020; 21 (03) 315-319
    CrossrefPubMedGoogle Scholar
  • 59 Ackermann M, Verleden SE, Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020; 383 (02) 120-128
    Google Scholar
  • 60 Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol 2022; 32 (04) e2315
    CrossrefPubMedGoogle Scholar
  • 61 Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens) 2021; 20 (01) 219-221
    CrossrefPubMedGoogle Scholar
  • 62 Suwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID-19: causality or coincidence? A report of three cases. J Med Virol 2021; 93 (02) 1150-1153
    CrossrefPubMedGoogle Scholar
  • 63 Copur S, Berkkan M, Basile C, Tuttle K, Kanbay M. Post-acute COVID-19 syndrome and kidney diseases: what do we know?. J Nephrol 2022; 35 (03) 795-805
    CrossrefPubMedGoogle Scholar
  • 64 McMahon DE, Gallman AE, Hruza GJ. et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis 2021; 21 (03) 313-314
    CrossrefPubMedGoogle Scholar
  • 65 Healey Q, Sheikh A, Daines L, Vasileiou E. Symptoms and signs of long COVID: a rapid review and meta-analysis. J Glob Health 2022; 12: 05014
    CrossrefPubMedGoogle Scholar
  • 66 Wilcox ME, Patsios D, Murphy G. et al. Radiologic outcomes at 5 years after severe ARDS. Chest 2013; 143 (04) 920-926
    CrossrefPubMedGoogle Scholar
  • 67 Wild JM, Porter JC, Molyneaux PL. et al. Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID). BMJ Open Respir Res 2021; 8 (01) e001049
    CrossrefPubMedGoogle Scholar
  • 68 Vijayakumar B, Tonkin J, Devaraj A. et al. CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge. Radiology 2022; 303 (02) 444-454
    CrossrefPubMedGoogle Scholar
  • 69 Borczuk AC, Salvatore SP, Seshan SV. et al. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol 2020; 33 (11) 2156-2168
    CrossrefPubMedGoogle Scholar
  • 70 Chen JY, Qiao K, Liu F. et al. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis. Chin Med J (Engl) 2020; 133 (12) 1390-1396
    CrossrefPubMedGoogle Scholar
  • 71 Polak SB, Van Gool IC, Cohen D, von der Thüsen JH, van Paassen J. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol 2020; 33 (11) 2128-2138
    CrossrefPubMedGoogle Scholar
  • 72 Ravaglia C, Doglioni C, Chilosi M. et al. Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J 2022; 60 (04) 2102411
    CrossrefPubMedGoogle Scholar
  • 73 Konopka KE, Perry W, Huang T, Farver CF, Myers JL. Usual interstitial pneumonia is the most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS-CoV-2. EClinicalMedicine 2021; 42: 101209
    CrossrefPubMedGoogle Scholar
  • 74 Fabbri L, Moss S, Khan FA. et al. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax 2022:thoraxjnl-2021-218275
    PubMedGoogle Scholar
  • 75 Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res 2022; 23 (01) 233
    CrossrefPubMedGoogle Scholar
  • 76 Besutti G, Monelli F, Schirò S. et al. Follow-up CT patterns of residual lung abnormalities in severe COVID-19 pneumonia survivors: a multicenter retrospective study. Tomography 2022; 8 (03) 1184-1195
    CrossrefPubMedGoogle Scholar
  • 77 Wu X, Liu X, Zhou Y. et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 2021; 9 (07) 747-754
    CrossrefPubMedGoogle Scholar
  • 78 Myall KJ, Mukherjee B, Castanheira AM. et al. Persistent post-COVID-19 interstitial lung disease. an observational study of corticosteroid treatment. Ann Am Thorac Soc 2021; 18 (05) 799-806
    CrossrefPubMedGoogle Scholar
  • 79 Dhooria S, Chaudhary S, Sehgal IS. et al. High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur Respir J 2022; 59 (02) 2102930
    CrossrefPubMedGoogle Scholar
  • 80 Bazdyrev E, Rusina P, Panova M, Novikov F, Grishagin I, Nebolsin V. Lung fibrosis after COVID-19: treatment prospects. Pharmaceuticals (Basel) 2021; 14 (08) 807
    CrossrefPubMedGoogle Scholar
  • 81 Bharat A, Machuca TN, Querrey M. et al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir Med 2021; 9 (05) 487-497
    CrossrefPubMedGoogle Scholar
  • 82 Cho JL, Villacreses R, Nagpal P. et al. Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology 2022; 304 (01) 185-192
    CrossrefPubMedGoogle Scholar
  • 83 Pednekar P, Amoah K, Homer R, Ryu C, Lutchmansingh DD. Case report: bullous lung disease following COVID-19. Front Med (Lausanne) 2021; 8: 770778
    CrossrefPubMedGoogle Scholar
  • 84 Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020; 18 (06) 1421-1424
    CrossrefPubMedGoogle Scholar
  • 85 Hippensteel JA, Burnham EL, Jolley SE. Prevalence of venous thromboembolism in critically ill patients with COVID-19. Br J Haematol 2020; 190 (03) e134-e137
    CrossrefPubMedGoogle Scholar
  • 86 Llitjos JF, Leclerc M, Chochois C. et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost 2020; 18 (07) 1743-1746
    CrossrefPubMedGoogle Scholar
  • 87 Konstantinides SV, Meyer G, Becattini C. et al; The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54 (03) x
    CrossrefPubMedGoogle Scholar
  • 88 Meneveau N, Ider O, Seronde MF. et al. Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism. Eur Heart J 2013; 34 (09) 693-701
    CrossrefPubMedGoogle Scholar
  • 89 Fernández-Capitán C, Barba R, Díaz-Pedroche MDC. et al. Presenting characteristics, treatment patterns, and outcomes among patients with venous thromboembolism during hospitalization for COVID-19. Semin Thromb Hemost 2021; 47 (04) 351-361
    Article in Thieme ConnectPubMedGoogle Scholar
  • 90 Tudoran C, Tudoran M, Lazureanu VE. et al. Evidence of pulmonary hypertension after SARS-CoV-2 infection in subjects without previous significant cardiovascular pathology. J Clin Med 2021; 10 (02) E199
    CrossrefPubMedGoogle Scholar
  • 91 D'Cruz RF, Waller MD, Perrin F. et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res 2021; 7 (01) 00655-2020
    CrossrefPubMedGoogle Scholar
  • 92 Mandal S, Barnett J, Brill SE. et al; ARC Study Group. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2021; 76 (04) 396-398
    CrossrefPubMedGoogle Scholar
  • 93 Song WJ, Hui CKM, Hull JH. et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med 2021; 9 (05) 533-544
    CrossrefPubMedGoogle Scholar
  • 94 Esendağli D, Yilmaz A, Akçay Ş, Özlü T. Post-COVID syndrome: pulmonary complications. Turk J Med Sci 2021; 51 (SI-1): 3359-3371
    CrossrefPubMedGoogle Scholar
  • 95 Aparisi Á, Ybarra-Falcón C, García-Gómez M. et al. Exercise ventilatory inefficiency in post-COVID-19 syndrome: insights from a prospective evaluation. J Clin Med 2021; 10 (12) 2591
    CrossrefPubMedGoogle Scholar
  • 96 Luchian ML, Motoc A, Lochy S. et al. Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19. Diagnostics (Basel) 2021; 12 (01) 57
    CrossrefPubMedGoogle Scholar
  • 97 Motiejunaite J, Balagny P, Arnoult F. et al. Hyperventilation: a possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors?. Front Physiol 2021; 11: 614590
    CrossrefPubMedGoogle Scholar
  • 98 Singh I, Joseph P, Heerdt PM. et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest 2022; 161 (01) 54-63
    CrossrefPubMedGoogle Scholar
  • 99 Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail 2021; 9 (12) 927-937
    CrossrefPubMedGoogle Scholar
  • 100 Motiejunaite J, Balagny P, Arnoult F. et al. Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors. Eur Respir J 2021; 58 (02) 2101578
    CrossrefPubMedGoogle Scholar
  • 101 Skjørten I, Ankerstjerne OAW, Trebinjac D. et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J 2021; 58 (02) 2100996
    CrossrefPubMedGoogle Scholar
  • 102 Gluckman TJ, Bhave NM, Allen LA. et al; Writing Committee. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2022; 79 (17) 1717-1756
    CrossrefPubMedGoogle Scholar
  • 103 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323 (11) 1061-1069
    CrossrefPubMedGoogle Scholar
  • 104 Schaller T, Hirschbühl K, Burkhardt K. et al. Postmortem examination of patients with COVID-19. JAMA 2020; 323 (24) 2518-2520
    CrossrefPubMedGoogle Scholar
  • 105 Carvalho-Schneider C, Laurent E, Lemaignen A. et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021; 27 (02) 258-263
    CrossrefPubMedGoogle Scholar
  • 106 Huang L, Zhao P, Tang D. et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging 2020; 13 (11) 2330-2339
    CrossrefPubMedGoogle Scholar
  • 107 Puntmann VO, Carerj ML, Wieters I. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5 (11) 1265-1273
    CrossrefPubMedGoogle Scholar
  • 108 Rajpal S, Tong MS, Borchers J. et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol 2021; 6 (01) 116-118
    PubMedGoogle Scholar
  • 109 Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022; 28 (03) 583-590
    CrossrefPubMedGoogle Scholar
  • 110 Carmona-Torre F, Mínguez-Olaondo A, López-Bravo A. et al. Dysautonomia in COVID-19 patients: a narrative review on clinical course, diagnostic and therapeutic strategies. Front Neurol 2022; 13: 886609
    CrossrefPubMedGoogle Scholar
  • 111 Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res 2020; 30 (05) 449-451
    CrossrefPubMedGoogle Scholar
  • 112 Johansson M, Ståhlberg M, Runold M. et al. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep 2021; 3 (04) 573-580
    CrossrefPubMedGoogle Scholar
  • 113 Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a postinfectious entity?. Clin Microbiol Infect 2020; 26 (11) 1448-1449
    CrossrefPubMedGoogle Scholar
  • 114 Jamal SM, Landers DB, Hollenberg SM. et al. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J Am Coll Cardiol 2022; 79 (23) 2325-2330
    CrossrefPubMedGoogle Scholar
  • 115 Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI. Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol 2018; 72 (11) 1294-1309
    CrossrefPubMedGoogle Scholar
  • 116 Mao L, Jin H, Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77 (06) 683-690
    CrossrefPubMedGoogle Scholar
  • 117 Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol 2020; 19 (05) 383-384
    CrossrefPubMedGoogle Scholar
  • 118 Martillo MA, Dangayach NS, Tabacof L. et al. Postintensive care syndrome in survivors of critical illness related to coronavirus disease 2019: cohort study from a New York City Critical Care Recovery Clinic. Crit Care Med 2021; 49 (09) 1427-1438
    CrossrefPubMedGoogle Scholar
  • 119 Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8 (05) 416-427
    CrossrefPubMedGoogle Scholar
  • 120 Taquet M, Sillett R, Zhu L. et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including ,284,437 patients. Lancet Psychiatry 2022; 9 (10) 815-827
    CrossrefPubMedGoogle Scholar
  • 121 Graham EL, Clark JR, Orban ZS. et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 “long haulers”. Ann Clin Transl Neurol 2021; 8 (05) 1073-1085
    CrossrefPubMedGoogle Scholar
  • 122 Del Brutto OH, Wu S, Mera RM, Costa AF, Recalde BY, Issa NP. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort. Eur J Neurol 2021; 28 (10) 3245-3253
    CrossrefPubMedGoogle Scholar
  • 123 Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021; 57 (05) 418
    CrossrefPubMedGoogle Scholar
  • 124 Franke C, Berlit P, Prüss H. Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German Society of Neurology. Neurol Res Pract 2022; 4 (01) 28
    CrossrefPubMedGoogle Scholar
  • 125 Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: diagnosis and management. JAMA 2020; 323 (24) 2512-2514
    CrossrefPubMedGoogle Scholar
  • 126 Wisnivesky JP, Govindarajulu U, Bagiella E. et al. Association of vaccination with the persistence of post-COVID symptoms. J Gen Intern Med 2022; 37 (07) 1748-1753
    CrossrefPubMedGoogle Scholar
  • 127 de Oliveira Almeida K, Nogueira Alves IG, de Queiroz RS. et al. A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors. Chronic Illn 2022; (e-pub ahead of print) DOI: 10.1177/17423953221089309.
    CrossrefPubMedGoogle Scholar
  • 128 Belli S, Balbi B, Prince I. et al. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J 2020; 56 (04) 2002096
    CrossrefPubMedGoogle Scholar
  • 129 Day HLS. Exploring online peer support groups for adults experiencing long covid in the united kingdom: qualitative interview study. J Med Internet Res 2022; 24 (05) e37674
    CrossrefPubMedGoogle Scholar
  • 130 (CDC)., C.f.D.C.a.P. Future Directions and Resources: Evaluating and Caring for Patients with Post-COVID Conditions: Interim Guidance. 2022 Accessed June 14, 2021 at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-resources-future.html
    PubMedGoogle Scholar
  • 131 Herrera JE, Niehaus WN, Whiteson J. et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM R 2021; 13 (09) 1027-1043
    CrossrefPubMedGoogle Scholar
  • 132 Beauchamp MK. et al. Canadian Thoracic Society position statement on rehabilitation for COVID-19 and implications for pulmonary rehabilitation. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2021; 6 (01) 9-13
    CrossrefPubMedGoogle Scholar
  • 133 Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force. Eur Respir J 2020; 2002197
    CrossrefPubMedGoogle Scholar
  • 134 Rolin S, Chakales A, Verduzco-Gutierrez M. Rehabilitation strategies for cognitive and neuropsychiatric manifestations of COVID-19. Curr Phys Med Rehabil Rep 2022; 10 (03) 182-187
    CrossrefPubMedGoogle Scholar
  • 135 Cutler DM. The costs of long COVID. JAMA Health Forum 2022; 3 (05) e221809-e221809
    CrossrefPubMedGoogle Scholar